AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-135836030/xechem-international-forms-xechem.html" title="Facts and information about Xechem International forms Xechem UK Ltd; files orphan drug application in European Union (EU) for its Sickle Cell Disease (SCD) drug.">Xechem International forms Xechem UK Ltd; files orphan drug application in European Union (EU) for its Sickle Cell Disease (SCD) drug.</a>

Close Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.

Frequently asked questions about RSS feeds

Xechem International forms Xechem UK Ltd; files orphan drug application in European Union (EU) for its Sickle Cell Disease (SCD) drug.

Asia Africa Intelligence Wire

(From Chemical Business NewsBase - Press Release)

Xechem International Inc announced the formation of Xechem UK Ltd, a wholly owned subsidiary based in the UK. Xechem UK will facilitate Xechem International's entry into the European market for Nicosan/Hemoxin, its lead product for Sickle Cell Disease (SCD). The formation of Xechem UK Ltd is a strategic move on Xechem International's part to expedite the distribution of novel "orphan drugs" in the European Union (EU) market. An Orphan Drug application has been filed for Nicosan/Hemoxin with the European Medical Evaluation Agency (EMEA), for …

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Xechem's Orphan Drug Status approved for its Sickle Cell medicine in the...: News wire article from: Asia Africa Intelligence Wire October 4, 2005 700+ words

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily